SCHEMBL31425090

SCHEMBL31425090

Cc1cccc(-c2nc(-c3cc(-c4cnccc4C)c(F)c(C)n3)no2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.55
▸ NPC1 O15118 8/20 0.55
▸ GRM5 P41594 2/20 0.55
▸ SMN1; SMN2 Q16637 6/20 0.48
▸ TP53 P04637 4/20 0.48
▸ S1PR1 P21453 4/20 0.45
▸ S1PR3 Q99500 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ AHR P35869 1/20 0.45
▸ CYP17A1 P05093 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31425128 0.92 TP53 (0.55) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425139 0.90 NPC1 (0.53) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425122 0.88 S1PR1 (0.44) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425176 0.88 RAB9A (0.47) RAB9ANPC1SMN1; SMN2TP53S1PR1
SCHEMBL31425177 0.87 CHRNB2 (0.56) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425180 0.84 NPC1 (0.42) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425203 0.84 NPC1 (0.42) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425185 0.83 NPC1 (0.54) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425181 0.82 NPC1 (0.40) RAB9ANPC1GRM5SMN1; SMN2TP53
SCHEMBL31425210 0.82 NPC1 (0.39) RAB9ANPC1GRM5SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026743-A1 HETEROARYL-LINKED ANALOGS AS MGLU5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME VANDERBILT UNIVERSITY 2025-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026743-A1 HETEROARYL-LINKED ANALOGS AS MGLU5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME GRM5, GRIK5, GRM2 RAB9A 1608/4885NPC1 2428/4885GRM5 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback